Retosiban

DB11818InvestigationalSmall molecule

Retosiban has been used in trials studying the treatment of Premature Labor and Obstetric Labour, Premature.

Chemical structure of Retosiban
Mechanism
Curator reviewed
Formula / weight
C27H34N4O5 · 494.592 g/mol (avg)
Code names
GSK-221149 · GSK-221149A

Resolves to

Compound
UNIIGIE06H28OXCAS820957-38-8ChEMBLCHEMBL429736PubChem11340891
Structure
InChIKeyPLVGDGRBPMVYPB-FDUHJNRSSA-NSMILESCC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)C2=COC(C)=N2)C(=O)[C@H](NC1=O)C1CC2=CC=CC=C2C1
Targets
P30559OXTR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Retosiban, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In